VerifiedVerified Supplier
IndependentCitation-BackedUpdated May 2026
Peptide Dosing Guides: Research Protocol Database
Find the dosing schedule, reconstitution math, and clinical references for any peptide, all in one place. Every protocol follows the same standardized format so you can compare compounds, check half-lives, and verify syringe units without hunting across five different sites.
Browse protocols organized by compound or by goal. Each guide includes phase-by-phase dosing, reconstitution tables with worked examples, side effects from clinical trials, and links to the free PepPal calculator for custom vial math.
Browse by Research Goal
Browse Peptide Protocols by Goal
Not sure where to start? Choose a research goal below. Each category links to the protocols most commonly studied for that purpose, with dosing schedules, reconstitution math, and clinical trial references included.
Weight Loss & Metabolic Support
GLP-1 agonists, dual and triple incretins, lipolytic fragments
Tissue Repair & Recovery
Healing peptides for tendons, ligaments, gut, and post-surgery recovery
Growth Hormone Optimization
GH secretagogues and releasing hormones for body composition and recovery
Skin, Collagen & Anti-Aging
Copper peptides, gene modulators, and collagen-remodeling compounds
Cognitive & Nootropic
Neuropeptides for focus, memory, and neuroplasticity
Longevity & Cellular Health
Mitochondrial peptides and NAD+ optimization
Sexual Health & Hormonal
Melanocortin and oxytocin-pathway compounds
Anti-Inflammatory & Gut Health
NF-kB modulators and gut-barrier peptides
Quick Reference
Peptide Dosage Quick Reference Chart
This table shows the essential dosing data for every compound in our database at a glance. For full protocols with titration schedules, reconstitution math, side effects, and clinical trial references, click any peptide name.
| Peptide | Category | Dose Range | Frequency | Half-Life | Route | |
|---|---|---|---|---|---|---|
| AOD-9604 | Lipolytic Fragment | 300–500 mcg/day | Daily | ~4 min (plasma) | SubQ | View |
| BPC-157 | Tissue Repair | 250–500 mcg/day | Daily | ~4 hours | SubQ / Oral | View |
| Bremelanotide (PT-141) | Sexual Health | 1–2 mg | As needed | ~2.5 hours | SubQ | View |
| Cagrilintide | Amylin Analog | 1.2–4.5 mg/week | Weekly | ~5 days | SubQ | View |
| CJC-1295 (DAC) | GH Secretagogue | 1–2 mg/week | 1–2x weekly | ~8 days | SubQ | View |
| CJC-1295 (No DAC) | GH Secretagogue | 100 mcg | 2–3x daily | ~30 min | SubQ | View |
| DSIP | Sleep Peptide | 100–300 mcg | Evening | Short | SubQ | View |
| GHK-Cu | Copper Peptide | 1–2 mg/day | Daily | ~1 hour | SubQ / Topical | View |
| Humanin | Mitochondrial | 0.5–2 mg/day | Daily | Short | SubQ | View |
| IGF-1 LR3 | Growth Factor | 20–60 mcg/day | Daily | 20–30 hours | SubQ / IM | View |
| Ipamorelin | GH Secretagogue | 200–300 mcg | 2–3x daily | ~2 hours | SubQ | View |
| Kisspeptin | Hormonal Signaling | 50–200 mcg | 1–2x daily | ~4 min | SubQ | View |
| KPV | Anti-Inflammatory | 200–500 mcg/day | Daily | Short (tripeptide) | SubQ / Oral | View |
| Melanotan II | Melanocortin | 250–500 mcg | 2–3x weekly | ~1 hour | SubQ | View |
| MOTS-c | Mitochondrial | 5–10 mg | 2–3x weekly | ~1–2 hours | SubQ | View |
| NAD+ | Cellular Health | 50–100 mg | 2–3x weekly | Variable | SubQ / IV | View |
| Oxytocin | Neuropeptide | 10–40 IU | As needed | ~3–5 min | Intranasal / SubQ | View |
| Retatrutide | Triple Agonist | 1–12 mg/week | Weekly | ~6 days | SubQ | View |
| Selank | Nootropic | 250–750 mcg/day | Daily | ~5 min | Intranasal / SubQ | View |
| Semaglutide | GLP-1 Agonist | 0.25–2.4 mg/week | Weekly | ~7 days | SubQ | View |
| Semax | Nootropic | 200–600 mcg/day | Daily | ~5 min | Intranasal | View |
| Sermorelin | GH Secretagogue | 200–500 mcg/day | Daily (PM) | ~10–20 min | SubQ | View |
| SLU-PP-332 | Exercise Mimetic | 100–300 mcg/day | Daily | Preclinical | Oral / Research | View |
| SS-31 | Mitochondrial | 4–40 mg/day | Daily | ~2–4 hours | SubQ | View |
| TB-500 | Tissue Repair | 2–5 mg | 2x weekly | ~Long-acting | SubQ | View |
| Tesamorelin | GH Secretagogue | 1–2 mg/day | Daily | ~26–38 min | SubQ | View |
| Tesofensine | Metabolic | 0.25–1 mg/day | Daily | ~9 days | Oral | View |
| Thymosin Alpha-1 | Immune Peptide | 1.6 mg | 2x weekly | ~2 hours | SubQ | View |
| Tirzepatide | Dual Agonist | 2.5–15 mg/week | Weekly | ~5 days | SubQ | View |
Every protocol page includes a full titration schedule, reconstitution table with syringe-unit conversions, side effects with clinical trial percentages, and numbered source citations.
Need syringe units for a specific vial size? Use the free PepPal Reconstitution Calculator. Open Calculator →
Protocol + Stack Directory
Browse All Research Protocols & Stacks
Alphabetized index for rapid protocol and stack discovery by compound and stack name.
Peptide Dosing Protocols is an independent, educational research database cataloging dosing schedules, reconstitution mathematics, half-life references, and stacking guidance for over 120 research peptides. Every protocol entry is structured for rapid reference, including phase-specific dosing tiers, injection frequency, vial reconstitution ratios with bacteriostatic water, and storage requirements.
Whether you're reviewing a GLP-1 metabolic protocol like retatrutide or tirzepatide, a tissue-repair compound like BPC-157 or TB-500, or a growth hormone secretagogue stack like CJC-1295 with Ipamorelin, each entry follows a standardized format designed for clarity and cross-referencing. Reconstitution math is simplified with our integrated calculator to convert vial sizes, diluent volumes, and syringe units quickly.
All protocols are compiled from published clinical trial data, peer-reviewed literature, and community research documentation. This site is strictly for educational and research reference purposes. No compounds listed are intended for human consumption. Browse the full A-Z directory below or select a featured protocol or stack to begin.
65 indexed entries
5
1 entriesB
1 entriesC
8 entriesD
2 entriesE
2 entriesF
2 entriesG
6 entriesI
2 entriesK
3 entriesL
2 entriesN
2 entriesO
1 entriesT
7 entriesW
1 entriesBlood TestAt-Home Blood Test
SiPhox Health At-Home Blood Test
View Blood TestInjection Supplies
Injection syringes
U-100 insulin syringes.
Alcohol swabs
Single-use prep pads.
Lockable peptide fridge
Lockable mini fridge.
Peptide storage case
Compact travel case.
disclosure: supply links may earn PDP a commission at no cost to you.
Stacking Protocols
Multi-Peptide Stack Protocols
Peptide stacking means using two or more compounds together to target complementary biological pathways. Each stack protocol below includes per-compound dosing, separate-vial and pre-blended reconstitution math, cycle length guidance, and a comparison to alternative stacks.
Tissue Repair
Wolverine Stack
BPC-157 + TB-500
Two-peptide repair stack combining localized and systemic recovery pathways. The most widely referenced recovery combination in the peptide community.
View Protocol →Repair + Skin Quality
GLOW Stack
BPC-157 + TB-500 + GHK-Cu
Three-peptide stack extending the Wolverine foundation with collagen remodeling and copper-peptide tissue quality support.
View Protocol →Repair + Anti-Inflammatory
KLOW Stack
BPC-157 + TB-500 + GHK-Cu + KPV
Four-peptide stack adding dedicated anti-inflammatory and gut-barrier support to the GLOW framework.
View Protocol →Growth Hormone
CJC-1295 + Ipamorelin GH Pulse Stack
CJC-1295 + Ipamorelin
Classic "push-pull" GH secretagogue combination targeting both pulse amplitude (GHRH) and pulse frequency (ghrelin receptor).
View Protocol →Weight Loss
CagriSema
Cagrilintide + Semaglutide
Novo Nordisk’s dual amylin-GLP-1 combination. Phase 3 REDEFINE trials showed 20.4% weight loss at 68 weeks.
View Protocol →Weight Loss
Cagrilintide + Tirzepatide
Cagrilintide + Tirzepatide
Experimental amylin + dual-incretin combination targeting three satiety pathways simultaneously.
View Protocol →Weight Loss
Cagrilintide + Retatrutide
Cagrilintide + Retatrutide
Amylin analog paired with triple-agonist GLP-1/GIP/glucagon for maximum metabolic pathway coverage.
View Protocol →Weight Loss + Mitochondrial Support
Retatrutide + MOTS-c
Retatrutide + MOTS-c
Triple-agonist retatrutide paired with MOTS-c for a mitochondrial-focused metabolic stack centered on fat-oxidation support during a deep deficit.
View Protocol →Cognitive
Russian Nootropic Stack
Selank + Semax
Two-peptide nootropic combination pairing anxiolytic and neurotrophic pathways for focus and stress resilience.
View Protocol →Body Composition
Advanced Recomp Stack
Multi-compound
Multi-compound protocol targeting GH optimization, metabolic rate, and tissue remodeling simultaneously.
View Protocol →Request Next Coverage
Don't see a dosing guide for your peptide or stack? Request it.
Send the compound or stack you want researched next. These requests help prioritize upcoming protocol coverage, especially for compounds that are moving from forum chatter into active research demand.
Emerging GLP-1 combinations
Lesser-known repair compounds
Custom stack demand signals
Standardized Format
What You Get in Every Protocol Guide
Every protocol page on this site follows the same standardized 14-section format. This means you can compare any two compounds directly — the dosing table is always in the same place, the reconstitution math always uses the same layout, and the clinical trial data is always organized the same way.
1
Quick Reference Card
Peptide name, aliases, category, half-life, dose range, vial sizes, regulatory status, and key clinical stat. Scannable in five seconds.
2
Overview
What the compound is, how it was developed, and its current clinical status. Written in plain language with the technical detail to back it up.
3
Mechanism of Action
How the peptide works at the receptor and pathway level. Each pathway is explained with what it does, not just what it is.
4
Dosing Protocol & Titration Schedule
Phase-by-phase dosing table with named phases, week ranges, doses, and notes. Includes missed dose guidance and flexibility notes.
5
Reconstitution Guide
Vial-size-specific reconstitution table showing BAC water volume, resulting concentration, dose-to-volume conversions, and syringe units.
6
Side Effects & Safety Profile
Specific percentages from clinical trials organized by category. No hedge language — if 25% of trial participants had nausea, the page says so.
7
Clinical Trial Data
Outcomes table with trial name, phase, duration, population, and headline result. Includes ongoing trial IDs from ClinicalTrials.gov.
8
Storage & Handling
Lyophilized and reconstituted storage requirements.
9
Comparison Table
Side-by-side comparison with 2–3 related compounds across receptor targets, half-life, dosing, efficacy, and FDA status.
10
Stacking Protocols
Links to any stack pages featuring this compound, with rationale.
11
Supplier Section
COA-verified suppliers with independent quality references.
12
FAQ
10–12 questions with complete, data-backed answers marked up for FAQ schema.
13
Sources & Research Papers
Numbered citation list with PubMed, NEJM, Lancet, and ClinicalTrials.gov links.
14
Related Protocols
Cards linking to related compounds and stacks.
This structure exists so you never have to guess where to find the information you need. Every protocol, every compound, same format.
Reconstitution Lab Notes
Reconstitution Quick Reference
Reconstitution is the process of dissolving freeze-dried peptide powder with bacteriostatic water to create an injectable solution. Getting the math right determines your dose accuracy. Here is the core formula and a worked example — every protocol page includes compound-specific reconstitution tables.
Concentration (mcg/mL) = Total peptide in vial (mcg) ÷ BAC water added (mL)
Dose volume (mL) = Target dose (mcg) ÷ Concentration (mcg/mL)
Syringe units = Dose volume (mL) × 100 (for U-100 insulin syringes)
Example: 10 mg BPC-157 vial + 2 mL bacteriostatic water
→ 10,000 mcg ÷ 2 mL = 5,000 mcg/mL concentration
→ For a 500 mcg dose: 500 ÷ 5,000 = 0.10 mL
→ 0.10 mL × 100 = 10 units on a U-100 syringe
Before You Inject, Verify
- Vial peptide content confirmed (check label — mg, not mcg)
- BAC water volume matches your target concentration
- Syringe units calculated from concentration, not guessed
- Reconstitution date labeled on vial
- Vial stored at 2–8°C after reconstitution
Editorial Standards
About This Database
Peptide Dosing Protocols is an independent research reference database. It is not affiliated with any peptide manufacturer, supplier, or clinic. All protocols are compiled from published clinical trial data, peer-reviewed literature, and clearly labeled community protocols.
Every protocol page follows the same standardized 14-section format so you can compare compounds consistently. Dosing data comes from clinical trials when available. When clinical trial dosing data does not exist for a compound, community-derived protocols are used and clearly labeled as such.
Reconstitution math is verified against the formula on every page — you can check it yourself. Clinical trial citations link to PubMed, NEJM, Lancet, and ClinicalTrials.gov so you can verify every claim against the primary source.
This database is maintained by Garret Grant, an independent researcher and founder of Peptide Dosing Protocols. Garret holds a B.S. in Civil Engineering from UCLA and applies an engineering-discipline approach to peptide protocol documentation: standardized formats, verified math, and traceable citations.
This is not medical advice. All compounds discussed are for educational and research reference purposes only. No compounds listed on this site are intended for human consumption. Consult a qualified healthcare professional before considering any peptide protocol.
Read full editorial standards and methodology →Important Reading
Disclaimer
The information provided on this website is for educational and reference purposes only. None of the compounds discussed are intended for human consumption. This is not medical advice.
By using this site, you acknowledge these protocols are for theoretical research environments only.
FTC Affiliate Disclosure
This site contains affiliate links. We may earn a commission from vetted partners at no additional cost to you. For current partner savings, see our peptide discount codes.
Editorial standards prioritize research transparency over promotion.
Frequently Asked Questions
What is Peptide Dosing Protocols?
Peptide Dosing Protocols is an independent research reference database with dosing guides, reconstitution math, clinical trial citations, and stacking protocols for 36 peptide compounds and 11 multi-compound stacks. That gives the site 47 published guides in total. Every protocol follows a standardized 14-section format.
How do you reconstitute a peptide vial?
Dissolve lyophilized peptide powder with bacteriostatic water. The concentration equals total peptide (mcg) divided by water volume (mL). For example, a 10 mg vial with 2 mL BAC water gives 5,000 mcg/mL. A 500 mcg dose at that concentration is 0.10 mL or 10 units on a U-100 syringe.
What peptide dosage chart does this site include?
The homepage includes a quick reference dosage chart showing dose range, frequency, half-life, and route of administration for 29 currently listed compounds. Each row links to the full protocol page with titration schedules, reconstitution tables, side effects, and clinical trial data.
What is peptide stacking?
Peptide stacking is the concurrent use of multiple compounds targeting complementary biological pathways. This site includes 11 stack protocols such as the Wolverine Stack (BPC-157 + TB-500) and KLOW Stack (BPC-157 + TB-500 + GHK-Cu + KPV), each with per-compound dosing, blend math, and cycle guidance. For a broader overview, read the Peptide Stacking 101 guide.
Are these protocols medical advice?
No. All protocols on this site are for educational and research reference purposes only. No compounds listed are intended for human consumption. Always consult a qualified healthcare professional before considering any peptide protocol.
Where does the dosing data come from?
Dosing data comes from published clinical trials and peer-reviewed literature when available. When clinical trial dosing data does not exist for a compound, community-derived protocols are used and clearly labeled. All sources are cited with PubMed, NEJM, Lancet, or ClinicalTrials.gov links.
How do I calculate syringe units for a peptide dose?
Divide your target dose (mcg) by your reconstituted concentration (mcg/mL) to get the volume in mL. Multiply by 100 to convert to units on a U-100 insulin syringe. For example: 250 mcg / 5,000 mcg/mL = 0.05 mL = 5 units. Use the PepPal Calculator for any custom combination.